Found 22 matching trials
Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4) PHASE3 Primary Objective:
To demonstrate the vaccine seroresponse sufficiency of ...
Show More Location
Investigational Site Number 8400012
Learn More & Join Trial
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population PHASE3 The scientific name of meningococcus is Neisseria meningitidis (Nm), the ca...
Show More Location
Shanyang County Center for Disease Prevention and Control
Learn More & Join Trial
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years PHASE3 This is a multicenter, randomized, double-blinded, positive controlled stud...
Show More Location
Husada Utama Hospital
Learn More & Join Trial
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years PHASE3 The purpose of this study is to evaluate the immunogenicity and safety of G...
Show More Location
Hunan Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old PHASE2 Phase 2/3 study to evaluate immunogenicity and safety in healthy adult part...
Show More Location
The Catholic University of Eunpyeong St.Mary's Hospital
Learn More & Join Trial
Study of Adolescent Immunization Recall Systems NA The purpose of this study is to determine whether contacting the parents of...
Show More Location
Children's Hospital Boston
Learn More & Join Trial
Safety Study of GBS Following Menactra Meningococcal Vaccination N/A We are conducting a large, record-based study to assess the risk of Guillai...
Show More Learn More & Join Trial
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. PHASE2 Primary objective is to evaluate the immune response to vaccination with te...
Show More Learn More & Join Trial
Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants PHASE4 This study is an open, multicenter Phase IV clinical study to evaluate the ...
Show More Location
Nanjing Luhe District Center for Disease Control and Prevention Center for Disease Control and Prevention
Learn More & Join Trial
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) PHASE4 The purpose of this clinical study is to evaluate the immunogenicity and im...
Show More Status
Active Not Recruiting
Location
Wuzhi County Center for Disease Control and Prevention
Learn More & Join Trial